Serum anti‐Mullerian hormone levels across different ethnic groups: a cross‐sectional study
暂无分享,去创建一个
R. Homburg | P. Bhide | A. Gudi | Amit Shah | A. Shah | Roy Homburg | R. Homburg
[1] M. Meseguer,et al. Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women. , 2014, Fertility and sterility.
[2] S. Iliodromiti,et al. The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. , 2014, Human reproduction update.
[3] K. Jayaprakasan,et al. Effect of ethnicity on live birth rates after in vitro fertilisation or intracytoplasmic sperm injection treatment , 2013, BJOG : an international journal of obstetrics and gynaecology.
[4] S. Gregorich,et al. Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women. , 2014, Fertility and sterility.
[5] D. Seifer,et al. Potential Mechanisms for Racial and Ethnic Differences in Antimüllerian Hormone and Ovarian Reserve , 2013, International journal of endocrinology.
[6] D. Barad,et al. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene , 2012, Reproductive Biology and Endocrinology.
[7] Nicholas A. Johnson,et al. Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities , 2012, Human Genetics.
[8] Nicholas A. Johnson,et al. Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women , 2011, Human reproduction.
[9] Sesh Kamal Sunkara,et al. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. , 2011, Human reproduction.
[10] D. Seifer,et al. Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: Society for Assisted Reproductive Technology 1999 and 2000 vs. 2004-2006. , 2010, Fertility and sterility.
[11] Mardge H. Cohen,et al. Variations in serum müllerian inhibiting substance between white, black, and Hispanic women. , 2009, Fertility and sterility.
[12] D. Barad,et al. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. , 2009, Reproductive biomedicine online.
[13] P. Bischof,et al. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. , 2008, Fertility and sterility.
[14] M. Croughan,et al. Asian ethnicity is associated with reduced pregnancy outcomes after assisted reproductive technology. , 2007, Fertility and sterility.
[15] Hui Lin,et al. Association of anti-mullerian hormone levels with obesity in late reproductive-age women. , 2007, Fertility and sterility.
[16] A. Volpe,et al. Serum anti-Mullerian hormone throughout the human menstrual cycle. , 2006, Human reproduction.
[17] P. Claman. Men at risk: occupation and male infertility. , 2004, Fertility and sterility.
[18] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.
[19] B. Fauser,et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.
[20] U. Vitt,et al. Perspective: the ovarian kaleidoscope database-II. Functional genomic analysis of an organ-specific database. , 2002, Endocrinology.
[21] F. Sharara,et al. Differences in in vitro fertilization (IVF) outcome between white and black women in an inner-city, university-based IVF program. , 2000, Fertility and sterility.
[22] J. Bland,et al. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women , 1998, Clinical endocrinology.